ATE75602T1 - Spruehgetrocknetes acetaminophen. - Google Patents

Spruehgetrocknetes acetaminophen.

Info

Publication number
ATE75602T1
ATE75602T1 AT87309253T AT87309253T ATE75602T1 AT E75602 T1 ATE75602 T1 AT E75602T1 AT 87309253 T AT87309253 T AT 87309253T AT 87309253 T AT87309253 T AT 87309253T AT E75602 T1 ATE75602 T1 AT E75602T1
Authority
AT
Austria
Prior art keywords
acetaminophene
spray dried
acetaminophen
spray
powder
Prior art date
Application number
AT87309253T
Other languages
English (en)
Inventor
Robert George Blank
Gerald Louis Reuter
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of ATE75602T1 publication Critical patent/ATE75602T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Glanulating (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT87309253T 1986-10-21 1987-10-20 Spruehgetrocknetes acetaminophen. ATE75602T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/921,558 US4771077A (en) 1986-10-21 1986-10-21 Spray dried acetaminophen
EP87309253A EP0265226B1 (de) 1986-10-21 1987-10-20 Sprühgetrocknetes Acetaminophen

Publications (1)

Publication Number Publication Date
ATE75602T1 true ATE75602T1 (de) 1992-05-15

Family

ID=25445622

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87309253T ATE75602T1 (de) 1986-10-21 1987-10-20 Spruehgetrocknetes acetaminophen.

Country Status (14)

Country Link
US (1) US4771077A (de)
EP (1) EP0265226B1 (de)
JP (1) JP2550363B2 (de)
KR (1) KR950013752B1 (de)
AT (1) ATE75602T1 (de)
AU (1) AU590980B2 (de)
CA (1) CA1298199C (de)
DE (1) DE3778825D1 (de)
ES (1) ES2032295T3 (de)
GR (1) GR3005045T3 (de)
IE (1) IE61950B1 (de)
NZ (1) NZ222110A (de)
PH (1) PH24376A (de)
ZA (1) ZA877542B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5130140A (en) * 1989-09-14 1992-07-14 Hoeschst-Roussel Pharmaceuticals Inc. Method of making direct dry compressible acetaminophen composition
US5198228A (en) * 1989-09-14 1993-03-30 Hoechst-Roussel Pharmaceuticals Inc. Direct dry compressible acetaminophen tablet
US5037658A (en) * 1989-09-14 1991-08-06 Hoechst-Roussel Pharmaceuticals, Inc. Direct dry compressible acetaminophen composition
EP0421582A1 (de) * 1989-10-03 1991-04-10 Warner-Lambert Company Kaubare sprühgetrocknete spheroide Mikrokapseln, polymerüberzogene Mikrokapseln und Verfahren zu ihrer Herstellung
SK282071B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta dispergovateľná vo vode a spôsob jej prípravy
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
DK0701434T3 (da) * 1993-06-04 2002-11-18 Warner Lambert Co Præparater indeholdende siliciumdioxid til forbedring af deres smag
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
AU699192B2 (en) * 1993-08-13 1998-11-26 Bayer Corporation Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
AU751497B2 (en) * 1996-04-23 2002-08-15 Mayne Pharma International Pty Ltd Taste masked pharmaceutical compositions
AUPO637197A0 (en) * 1997-04-23 1997-05-15 F.H. Faulding & Co. Limited Taste-masked pharmaceutical compositions
AUPN940796A0 (en) * 1996-04-23 1996-05-16 F.H. Faulding & Co. Limited Taste masked pharmaceutical compositions
US20040162273A1 (en) * 2003-01-23 2004-08-19 The Procter & Gamble Company Powder pharmaceutical compositions
JP5026675B2 (ja) * 2005-03-08 2012-09-12 洋文 竹内 錠剤、およびその製造方法
US20060292214A1 (en) * 2005-06-03 2006-12-28 Elan Pharma International Limited Nanoparticulate acetaminophen formulations
GB2443793B (en) * 2006-04-05 2010-12-01 Reckitt Benckiser Healthcare Product, method of manufacture and use
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
US20210106717A1 (en) * 2019-10-10 2021-04-15 Cook Medical Technologies Llc Bonded powders for the treatment of bodily lesions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5420572B2 (de) * 1973-04-27 1979-07-24
US4013785A (en) * 1975-03-21 1977-03-22 Bristol-Myers Company Apap tablet containing fumed silica and process for manufacturing same
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
EP0040472B1 (de) * 1980-05-20 1986-01-29 Mallinckrodt, Inc. (a Delaware corporation) Trockenpulverisierte N-Acetyl-p-aminophenol-Zusammensetzungen und Verfahren zu deren Herstellung
JPS58172311A (ja) * 1982-04-02 1983-10-11 Kodama Kk 持続性製剤及びその製法
DE3306012A1 (de) * 1983-02-22 1984-08-23 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung eines freifliessenden paracetamol-granulats
US4600579A (en) * 1983-06-07 1986-07-15 Mallinckrodt, Inc. N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
US4533674A (en) * 1983-10-24 1985-08-06 Basf Wyandotte Corporation Process for preparing a sugar and starch free spray-dried vitamin C powder containing 90 percent ascorbic acid
WO1985003439A1 (en) * 1984-02-08 1985-08-15 R.P. Scherer Corporation Acetaminophen gelatin capsule providing rapid onset of therapeutic activity upon oral administration
US4710519A (en) * 1985-09-30 1987-12-01 Basf Corporation Process for preparing spray dried acetaminophen powder and the powder prepared thereby

Also Published As

Publication number Publication date
CA1298199C (en) 1992-03-31
ZA877542B (en) 1989-05-30
AU7951087A (en) 1988-04-28
KR880004805A (ko) 1988-06-27
IE61950B1 (en) 1994-11-30
PH24376A (en) 1990-06-13
EP0265226B1 (de) 1992-05-06
EP0265226A2 (de) 1988-04-27
ES2032295T3 (es) 1993-02-01
GR3005045T3 (de) 1993-05-24
US4771077A (en) 1988-09-13
KR950013752B1 (ko) 1995-11-15
AU590980B2 (en) 1989-11-23
DE3778825D1 (de) 1992-06-11
NZ222110A (en) 1989-07-27
JP2550363B2 (ja) 1996-11-06
EP0265226A3 (en) 1989-07-19
IE872749L (en) 1988-04-21
JPS63112515A (ja) 1988-05-17

Similar Documents

Publication Publication Date Title
ATE75602T1 (de) Spruehgetrocknetes acetaminophen.
DE3783332D1 (de) Spruehgetrocknetes acetaminophen.
DE3770116D1 (de) Spruehgetrocknetes acetaminophen.
ATE64309T1 (de) Spruehgetrocknetes acetaminophen.
LU91039I2 (fr) Proteq flu et ses dérivés pharmaceutiquement acceptables
NO874955L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaromatiske aminderivater.
NO176273C (no) Analogifremgangsmåte for fremstilling av aktive substituerte benzamider
FI871087A0 (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
NO165545C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye oksadiazolimidazo-benzodiazepinderivater.
NO168176C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider
NO164243C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive 16,17-acetalsubstituerte pregnan-21-oinsyrederivater
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
JPS5531096A (en) Novel compound bissindoline derivative active as drug and its manufacture
ES2012326A4 (es) Monoesteres del acido griseolico, su preparacion y empleo
IT7823016A0 (it) Composto farmaceutico di migliorata attivita' mucolitica e fluidificante delle secrezioni mucose.
HUT45231A (en) Process for producing sulfonamide derivatives of phenyl-sulfonamido-alkyl-amines and pharmaceuticals with antiarhythmic effect comprising the same as active ingredient
NO943458L (no) Fremgangsmåte for fremstilling av terapeutisk aktivt amphiregulin
NO174958C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive tetralinderivater
NO302577B1 (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive dekapeptider

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time